Stock screenerAll disclosures →
EDGAR →
RGNT
Conviction 43HealthcareScan · Mon, Jul 20, 2026RGNT$1.96-17.65%
ResistanceSupportVol 14Vol MA14 250.59K
Apr 20May 6May 26Jun 11Jul 1Jul 20
REGENTIS BIOMATERIALS LTD.www.regentis.co.il ↗
Price1.96
Change-17.65%
Gap+9.45%
Rel volume4.32×
Avg volume304.49K
Avg $ vol1.06M
SMA 203.50
SMA 502.90
SMA 200—
Price vs 50-32.42%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 4.33
RSI (14)39
MACD hist-0.27
MACD cross—
Stoch %K / %D2 / 5
ADX (14)40
+DI / −DI37 / 24
RSI divergence—
MACD divergence—
ATR %+39.65%
ADR %14.69%
52w high9.40
52w low0.0000
From 52w high-79.15%
Above 52w low—
New 52w highNo
SqueezeOff
Bollinger width85.09%
%B-0.02
Donchian pos1.46%
Donchian high5.00
Donchian low1.92
AVWAP (52w high)8.51
vs AVWAP high-76.97%
AVWAP (52w low)6.55
vs AVWAP low-70.10%
OBV trendDown
Chaikin MF (20)-0.29
Today vs 20d4.32×
Avg vol (14d)250.59K
Avg vol (20d)304.49K
Avg $ vol (20d)1.06M
Market cap10.15M
RS 3m (vs SPY)-31.56%
RS 6m (vs SPY)-71.81%
RS line new highNo
Trend template—
Technical rank3.5
1 week-43.52%
1 month-58.74%
3 months-35.74%
6 months-74.55%
1 year—
YTD—
P/E—
P/B2.14
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq0.25
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value3.97M
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeNYSE
Shares out5.18M
Employees8
ListedThu, Dec 4, 2025
Free float2.4M
Float %46.4%
Short interest143.05K
Days to cover0.1d
Short volume49.8%
Squeeze score34 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction43 / 100
Pattern quality—
Tech rank3.5 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.03
Support1.38
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in RGNT
No recent disclosed trades by Congress in RGNT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RGNT · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Alpert Susan PHD MD Director · Employee Stock Option (Right to Buy) · 2026-07-09 | Grant | 24.83K | — | 2026-07-09 | 2026-07-13 |
Ben-Elazar Pini Director · Employee Stock Option (Right to Buy) · 2026-07-09 | Grant | 24.83K | — | 2026-07-09 | 2026-07-13 |
Ben-Elazar Pini Director · Employee Stock Option (Right to Buy) · 2026-07-09 | Grant | 8.31K | — | 2026-07-09 | 2026-07-13 |
Cohen-Arazi Efraim Director · Employee Stock Option (Right to Buy) · 2026-07-09 | Grant | 24.83K | — | 2026-07-09 | 2026-07-13 |
Dykan Jeff Director · Warrants to purchase ordinary shares · 2026-07-09 | Grant | 12.5K | — | 2026-07-09 | 2026-07-13 |
Dykan Jeff Director · Employee Stock Option (Right to Buy) · 2026-07-09 | Grant | 24.83K | — | 2026-07-09 | 2026-07-13 |
GELLER EHUD Chief Executive Officer · Warrants to purchase ordinary shares · 2026-07-09 | Grant | 31.25K | — | 2026-07-09 | 2026-07-13 |
Valentine Keith Director · Employee Stock Option (Right to Buy) · 2026-07-09 | Grant | 24.83K | — | 2026-07-09 | 2026-07-13 |
SEC filings
EDGAR filings in RGNT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.